To The Moon

TopTop
7 x 247 x 24

No Content
Today
ImportanceALL
ALL
US
HK
CN
FUT
Refresh after 60 seconds
- 22:49
  Apk-Inform Increases Ukraine's 2025 Wheat Harvest Outlook to 23.2 Million Tons From 22.7 Million Tons
  22:30
  Genmab Announces Data From Multiple Clinical Trials Showing Treatment With Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (Dlbcl) and Follicular Lymphoma (Fl)
  22:00
  Viatris Announces Agreement to Monetize Its Equity Stake in Biocon Biologics Limited
  22:00
  Viatris Inc - Viatris to Receive $400 Mln in Cash and $415 Mln in Equity Shares of Biocon Limited
  21:48
  Indigo: Over 95% of Network Connectivity Has Been Re-Established as We're Able to Operate to 135 Out of the Existing 138 Destinations in Operations
  21:48
  Indigo - Today, We Are on Our Way to Operate Over 1500 Flights by End of Day
  21:48
  Indigo: Had Cancelled a Significant Number of Flights and Operated Little Above 700 Flights Yesterday Connecting 113 Destinations
  21:00
  Disc Medicine Presents Positive Initial Data From Rally-Mf Phase 2 Trial in Patients With Myelofibrosis (Mf) and Anemia at the 67TH American Society of Hematology (Ash) Annual Meeting
  21:00
  Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 Ash Annual Meeting; High Rate of Frontline Clinical Responses Continues Across Aml Populations
  21:00
  Beam Therapeutics Reports Updated Data From Beacon Phase 1/2 Trial of Ristoglogene Autogetemcel (Risto-Cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (Scd) at American Society of Hematology (Ash) Annual Meeting
  20:48
  India's Nov Diesel Sales up 4.7% Y/Y, Petrol Sales up 2.6% Y/Y - Govt
  20:01
  Vertex Presents New Data on Casgevy®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions
  20:00
  Vertex: Consistent With Studies in Older Patients, Children Treated With Casgevy Have Durable Increases in Fetal Hemoglobin & Stable Allelic Editing
  20:00
  Vertex Pharmaceuticals: Presents New Data on Casgevy, Including First-Ever Data in Children Ages 5-11 Years
  20:00
  Vertex Pharmaceuticals: Expects to Initiate Global Regulatory Submissions for Casgevy in Children 5-11 Years in 1H 2026

Most Discussed

{"tab":"breaking","data":{"breakingNews":{"listData":[{"content":"Apk-Inform Increases Ukraine's 2025 Wheat Harvest Outlook to 23.2 Million Tons From 22.7 Million Tons","isHighlight":0,"pubTime":1765032571000,"id":"2589826121","media":"THOMSON REUTERS","liveEventLiveId":null,"liveImageUrl":null,"symbols":[],"symbols_score_info":{},"liveRelated":null},{"content":"Genmab Announces Data From Multiple Clinical Trials Showing Treatment With Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (Dlbcl) and Follicular Lymphoma (Fl)","isHighlight":0,"pubTime":1765031400604,"id":"2589648826","media":"THOMSON REUTERS","liveEventLiveId":null,"liveImageUrl":null,"symbols":[],"symbols_score_info":{},"liveRelated":null},{"content":"Viatris Announces Agreement to Monetize Its Equity Stake in Biocon Biologics Limited","isHighlight":0,"pubTime":1765029600489,"id":"2589825025","media":"THOMSON REUTERS","liveEventLiveId":null,"liveImageUrl":null,"symbols":["VTRS"],"symbols_score_info":{"VTRS":0.9},"liveRelated":null},{"content":"Viatris Inc  - Viatris to Receive $400 Mln in Cash and $415 Mln in Equity Shares of Biocon Limited","isHighlight":0,"pubTime":1765029600489,"id":"2589082682","media":"THOMSON REUTERS","liveEventLiveId":null,"liveImageUrl":null,"symbols":["VTRS"],"symbols_score_info":{"VTRS":0.9},"liveRelated":null},{"content":"Indigo: Over 95% of Network Connectivity Has Been Re-Established as We're Able to Operate to 135 Out of the Existing 138 Destinations in Operations","isHighlight":0,"pubTime":1765028899710,"id":"2589825729","media":"THOMSON REUTERS","liveEventLiveId":null,"liveImageUrl":null,"symbols":[],"symbols_score_info":{},"liveRelated":null},{"content":"Indigo  - Today, We Are on Our Way to Operate Over 1500 Flights by End of Day","isHighlight":0,"pubTime":1765028899710,"id":"2589825743","media":"THOMSON REUTERS","liveEventLiveId":null,"liveImageUrl":null,"symbols":[],"symbols_score_info":{},"liveRelated":null},{"content":"Indigo:  Had Cancelled a Significant Number of Flights and Operated Little Above 700 Flights Yesterday Connecting 113 Destinations","isHighlight":0,"pubTime":1765028899710,"id":"2589257488","media":"THOMSON REUTERS","liveEventLiveId":null,"liveImageUrl":null,"symbols":[],"symbols_score_info":{},"liveRelated":null},{"content":"Disc Medicine Presents Positive Initial Data From Rally-Mf Phase 2 Trial in Patients With Myelofibrosis (Mf) and Anemia at the 67TH American Society of Hematology (Ash) Annual Meeting","isHighlight":0,"pubTime":1765026002868,"id":"2589913825","media":"THOMSON REUTERS","liveEventLiveId":null,"liveImageUrl":null,"symbols":["IRON"],"symbols_score_info":{"IRON":0.9},"liveRelated":null},{"content":"Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 Ash Annual Meeting; High Rate of Frontline Clinical Responses Continues Across Aml Populations","isHighlight":0,"pubTime":1765026002782,"id":"2589825918","media":"THOMSON REUTERS","liveEventLiveId":null,"liveImageUrl":null,"symbols":[],"symbols_score_info":{},"liveRelated":null},{"content":"Beam Therapeutics Reports Updated Data From Beacon Phase 1/2 Trial of Ristoglogene Autogetemcel (Risto-Cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (Scd) at American Society of Hematology (Ash) Annual Meeting","isHighlight":0,"pubTime":1765026000440,"id":"2589082599","media":"THOMSON REUTERS","liveEventLiveId":null,"liveImageUrl":null,"symbols":["BEAM"],"symbols_score_info":{"BEAM":0.9},"liveRelated":null},{"content":"India's Nov Diesel Sales up 4.7% Y/Y, Petrol Sales up 2.6% Y/Y - Govt","isHighlight":0,"pubTime":1765025281161,"id":"2589825635","media":"THOMSON REUTERS","liveEventLiveId":null,"liveImageUrl":null,"symbols":[],"symbols_score_info":{},"liveRelated":null},{"content":"Vertex Presents New Data on Casgevy®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions","isHighlight":0,"pubTime":1765022462989,"id":"2589237178","media":"THOMSON REUTERS","liveEventLiveId":null,"liveImageUrl":null,"symbols":["VRTX"],"symbols_score_info":{"VRTX":0.9},"liveRelated":null},{"content":"Vertex: Consistent With Studies in Older Patients, Children Treated With Casgevy Have Durable Increases in Fetal Hemoglobin & Stable Allelic Editing","isHighlight":0,"pubTime":1765022400000,"id":"2589823718","media":"THOMSON REUTERS","liveEventLiveId":null,"liveImageUrl":null,"symbols":["VRTX"],"symbols_score_info":{"VRTX":0.9},"liveRelated":null},{"content":"Vertex Pharmaceuticals: Presents New Data on Casgevy, Including First-Ever Data in Children Ages 5-11 Years","isHighlight":0,"pubTime":1765022400000,"id":"2589823797","media":"THOMSON REUTERS","liveEventLiveId":null,"liveImageUrl":null,"symbols":["VRTX"],"symbols_score_info":{"VRTX":0.9},"liveRelated":null},{"content":"Vertex Pharmaceuticals: Expects to Initiate Global Regulatory Submissions for Casgevy in Children 5-11 Years in 1H 2026","isHighlight":0,"pubTime":1765022400000,"id":"2589237158","media":"THOMSON REUTERS","liveEventLiveId":null,"liveImageUrl":null,"symbols":["VRTX"],"symbols_score_info":{"VRTX":0.9},"liveRelated":null}],"market":"all","onlyImportant":false}}}